Loading...

RN-Western Siberia

MISX:CHGZ
Snowflake Description

Flawless balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CHGZ
MISX
RUB817M
Market Cap
  1. Home
  2. RU
  3. Commercial Services
Company description

Public Joint Stock Company RN-Western Siberia provides legal, administrative, and archiving services in Russia. The last earnings update was 72 days ago. More info.


Add to Portfolio Compare Print
  • RN-Western Siberia has significant price volatility in the past 3 months.
CHGZ Share Price and Events
7 Day Returns
-3.2%
MISX:CHGZ
2.5%
Europe Professional Services
-0.8%
RU Market
1 Year Returns
-1.6%
MISX:CHGZ
10%
Europe Professional Services
7.6%
RU Market
CHGZ Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
RN-Western Siberia (CHGZ) -3.2% -12.9% 27.1% -1.6% -6.2% 45.2%
Europe Professional Services 2.5% 3.8% 10.6% 10% 32% 52.8%
RU Market -0.8% 2.6% 4.3% 7.6% 30.5% 93.5%
1 Year Return vs Industry and Market
  • CHGZ underperformed the Professional Services industry which returned 10% over the past year.
  • CHGZ underperformed the Market in Russian Federation which returned 7.6% over the past year.
Price Volatility
CHGZ
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for RN-Western Siberia's competitors could be found in our database.

Value

 Is RN-Western Siberia undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for RN-Western Siberia. This is due to cash flow or dividend data being unavailable. The share price is RUB30.5.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for RN-Western Siberia's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are RN-Western Siberia's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
MISX:CHGZ PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in RUB RUB2.00
MISX:CHGZ Share Price ** MISX (2019-04-18) in RUB RUB30.5
Europe Professional Services Industry PE Ratio Median Figure of 98 Publicly-Listed Professional Services Companies 17.66x
Russian Federation Market PE Ratio Median Figure of 130 Publicly-Listed Companies 7.39x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of RN-Western Siberia.

MISX:CHGZ PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= MISX:CHGZ Share Price ÷ EPS (both in RUB)

= 30.5 ÷ 2.00

15.25x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • RN-Western Siberia is good value based on earnings compared to the Europe Professional Services industry average.
  • RN-Western Siberia is overvalued based on earnings compared to the Russian Federation market.
Price based on expected Growth
Does RN-Western Siberia's expected growth come at a high price?
Raw Data
MISX:CHGZ PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 15.25x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
32%per year
Europe Professional Services Industry PEG Ratio Median Figure of 60 Publicly-Listed Professional Services Companies 1.46x
Russian Federation Market PEG Ratio Median Figure of 33 Publicly-Listed Companies 0.51x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for RN-Western Siberia, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on RN-Western Siberia's assets?
Raw Data
MISX:CHGZ PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in RUB RUB101.10
MISX:CHGZ Share Price * MISX (2019-04-18) in RUB RUB30.5
Europe Professional Services Industry PB Ratio Median Figure of 124 Publicly-Listed Professional Services Companies 2.38x
Russian Federation Market PB Ratio Median Figure of 150 Publicly-Listed Companies 0.83x
MISX:CHGZ PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= MISX:CHGZ Share Price ÷ Book Value per Share (both in RUB)

= 30.5 ÷ 101.10

0.3x

* Primary Listing of RN-Western Siberia.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • RN-Western Siberia is good value based on assets compared to the Europe Professional Services industry average.
X
Value checks
We assess RN-Western Siberia's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Professional Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Professional Services industry average (and greater than 0)? (1 check)
  5. RN-Western Siberia has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is RN-Western Siberia expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover RN-Western Siberia, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
32%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is RN-Western Siberia expected to grow at an attractive rate?
  • RN-Western Siberia's earnings growth is expected to exceed the low risk savings rate of 8.4%.
Growth vs Market Checks
  • RN-Western Siberia's earnings growth is expected to exceed the Russian Federation market average.
  • Unable to compare RN-Western Siberia's revenue growth to the Russian Federation market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
MISX:CHGZ Future Growth Rates Data Sources
Data Point Source Value (per year)
MISX:CHGZ Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 32%
Europe Professional Services Industry Earnings Growth Rate Market Cap Weighted Average 9.1%
Europe Professional Services Industry Revenue Growth Rate Market Cap Weighted Average 5.1%
Russian Federation Market Earnings Growth Rate Market Cap Weighted Average 3.8%
Russian Federation Market Revenue Growth Rate Market Cap Weighted Average 4.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
MISX:CHGZ Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in RUB Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
MISX:CHGZ Past Financials Data
Date (Data in RUB Millions) Revenue Cash Flow Net Income *
2018-12-31 42 -94 59
2018-09-30 41 61
2018-06-30 40 73
2018-03-31 39 90
2017-12-31 40 -92 107
2017-09-30 39 120
2017-06-30 39 176
2017-03-31 39 182
2016-12-31 37 -46 188
2016-09-30 36 187
2016-06-30 39 145
2016-03-31 39 118

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • RN-Western Siberia's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if RN-Western Siberia is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
MISX:CHGZ Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from RN-Western Siberia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

MISX:CHGZ Past Financials Data
Date (Data in RUB Millions) EPS *
2018-12-31 2.00
2018-09-30
2018-06-30
2018-03-31 3.37
2017-12-31 4.00
2017-09-30
2017-06-30
2017-03-31 6.80
2016-12-31 7.00
2016-09-30
2016-06-30 5.42
2016-03-31 4.39

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if RN-Western Siberia will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess RN-Western Siberia's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
RN-Western Siberia has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has RN-Western Siberia performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare RN-Western Siberia's growth in the last year to its industry (Professional Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • RN-Western Siberia's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • RN-Western Siberia's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • RN-Western Siberia's 1-year earnings growth is negative, it can't be compared to the Europe Professional Services industry average.
Earnings and Revenue History
RN-Western Siberia's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from RN-Western Siberia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

MISX:CHGZ Past Revenue, Cash Flow and Net Income Data
Date (Data in RUB Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 41.66 59.07 81.57
2018-09-30 40.76 61.23 84.28
2018-06-30 39.88 72.82 81.65
2018-03-31 39.45 90.11 75.53
2017-12-31 39.59 107.18 69.95
2017-09-30 39.46 119.89 63.45
2017-06-30 39.32 175.80 58.33
2017-03-31 38.66 182.14 56.38
2016-12-31 37.49 187.56 54.46
2016-09-30 36.50 186.54 63.14
2016-06-30 38.64 145.02 63.17
2016-03-31 38.91 117.66 67.95
2015-12-31 39.16 91.61 69.20
2015-09-30 38.77 69.16 65.69
2015-06-30 34.02 43.53 64.93
2015-03-31 31.75 48.95 57.31
2014-12-31 29.52 53.04 51.76
2014-09-30 34.88 62.71 45.78
2014-06-30 27.80 66.50 43.92
2014-03-31 20.97 68.77 38.36
2013-12-31 14.13 64.33 43.93
2013-09-30 0.45 70.55 30.04
2013-06-30 0.45 72.53 24.87
2013-03-31 0.45 79.70 23.61
2012-12-31 0.45 89.15 12.17
2012-09-30 0.46 91.82 9.10
2012-06-30 0.45 93.36 7.04

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • RN-Western Siberia has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • It is difficult to establish if RN-Western Siberia has efficiently used its assets last year compared to the Europe Professional Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if RN-Western Siberia improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess RN-Western Siberia's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Professional Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
RN-Western Siberia has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is RN-Western Siberia's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up RN-Western Siberia's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • RN-Western Siberia is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • RN-Western Siberia's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of RN-Western Siberia's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • RN-Western Siberia has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from RN-Western Siberia Company Filings, last reported 3 months ago.

MISX:CHGZ Past Debt and Equity Data
Date (Data in RUB Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 2,706.64 0.00 0.86
2018-09-30 2,692.89 0.00 0.59
2018-06-30 2,677.87 0.00 0.69
2018-03-31 2,663.84 0.00 0.63
2017-12-31 2,647.57 0.00 0.69
2017-09-30 2,631.66 0.00 0.33
2017-06-30 2,605.06 0.00 0.59
2017-03-31 2,573.73 0.00 0.40
2016-12-31 2,540.39 0.00 0.47
2016-09-30 2,511.77 0.00 0.44
2016-06-30 2,429.25 0.00 0.31
2016-03-31 2,391.59 0.00 0.34
2015-12-31 2,352.83 0.00 0.39
2015-09-30 2,325.23 0.00 0.67
2015-06-30 2,284.24 0.00 1,677.94
2015-03-31 2,273.93 0.00 1,678.43
2014-12-31 2,261.22 0.00 1,675.42
2014-09-30 2,256.08 0.00 1,673.43
2014-06-30 2,240.71 0.00 0.52
2014-03-31 2,224.98 0.00 0.47
2013-12-31 2,208.19 0.00 0.12
2013-09-30 2,193.37 0.00 0.30
2013-06-30 2,174.20 0.00 0.49
2013-03-31 2,156.21 0.00 6.11
2012-12-31 2,143.86 0.00 0.99
2012-09-30 2,122.81 0.00 7.18
2012-06-30 2,101.67 0.00 1,663.26
  • RN-Western Siberia has no debt.
  • RN-Western Siberia has not taken on any debt in the past 5 years.
  • RN-Western Siberia has no debt, it does not need to be covered by operating cash flow.
  • RN-Western Siberia has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess RN-Western Siberia's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. RN-Western Siberia has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is RN-Western Siberia's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from RN-Western Siberia dividends.
If you bought RUB2,000 of RN-Western Siberia shares you are expected to receive RUB0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate RN-Western Siberia's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate RN-Western Siberia's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
MISX:CHGZ Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Professional Services Industry Average Dividend Yield Market Cap Weighted Average of 77 Stocks 2.6%
Russian Federation Market Average Dividend Yield Market Cap Weighted Average of 75 Stocks 6.8%
Russian Federation Minimum Threshold Dividend Yield 10th Percentile 1.8%
Russian Federation Bottom 25% Dividend Yield 25th Percentile 3.2%
Russian Federation Top 25% Dividend Yield 75th Percentile 9.2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as RN-Western Siberia has not reported any payouts.
  • Unable to verify if RN-Western Siberia's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of RN-Western Siberia's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as RN-Western Siberia has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess RN-Western Siberia's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can RN-Western Siberia afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. RN-Western Siberia has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of RN-Western Siberia's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Buy Ivanovna
TENURE AS CEO 3.2 years
CEO Bio

Ms. Buy Natalya Ivanovna has been the General Director of JSC Chernogorneft since February 24, 2016, Belozerneft since May 17, 2016 and Priobneft OJSC since May 17, 2016.

CEO Compensation
  • Insufficient data for Buy to compare compensation growth.
  • Insufficient data for Buy to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team

Buy Ivanovna

TITLE
General Director
TENURE
3.2 yrs

T. Komarova

TITLE
Chief Accountant
Board of Directors Tenure

Average tenure of the RN-Western Siberia board of directors in years:

3.8
Average Tenure
  • The tenure for the RN-Western Siberia board of directors is about average.
Board of Directors

Sergey Bogdanov

TITLE
Chair of the Board of Directors

Natalya Chagaeva

TITLE
Director

Indira Nevretdinova

TITLE
Director

Marina Vorontsova

TITLE
Director

Stanislav Suleymanov

TITLE
Director

Aleksandr Makarov

TITLE
Director

Yudakov Viktorovich

TITLE
Director
AGE
54
TENURE
3.8 yrs

Aleksey Vershinin

TITLE
Member of the Audit Commission

Avramenko Igorevich

TITLE
Member of the Audit Commission
TENURE
3.8 yrs

Popov Vladislavovich

TITLE
Member of the Audit Commission
TENURE
3.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (RUB) Value (RUB)
X
Management checks
We assess RN-Western Siberia's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. RN-Western Siberia has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

How Did Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) 3.38% ROE Fare Against The Industry?

I am writing today to help inform people who are new to the stock market. … and want to begin learning the link between company’s fundamentals and stock market performance. … Public Joint Stock Company RN-Western Siberia (MCX:CHGZ) generated a below-average return on equity of 3.38% in the past 12 months, while its industry returned 16.40%.

Simply Wall St -

Is It Time To Buy Public Joint Stock Company RN-Western Siberia (MCX:CHGZ) Based Off Its PE Ratio?

and want to begin learning the link between Public Joint Stock Company RN-Western Siberia (MCX:CHGZ)’s fundamentals and stock market performance. … Public Joint Stock Company RN-Western Siberia (MCX:CHGZ) is trading with a trailing P/E of 8x, which is lower than the industry average of 20.8x. … While this makes CHGZ appear like a great stock to buy, you might change your mind after I explain the assumptions behind the P/E ratio

Simply Wall St -

What Should Investors Know About Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) Return On Capital?

Thus, to understand how your money can grow by investing in RN-Western Siberia, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE). … Check out our latest analysis for RN-Western Siberia RN-Western Siberia's Return On Capital Employed As an investor you have many alternative companies to choose from, which means there is an opportunity cost in any investment you make in the form of a foregone investment in another company. … I have calculated RN-Western Siberia’s ROCE for you below: ROCE Calculation for CHGZ Return on Capital Employed (ROCE) = Earnings Before Tax (EBT) ÷ (Capital Employed) Capital Employed = (Total Assets - Current Liabilities) ∴ ROCE = RUРУБ134.29M ÷ (RUРУБ2.67B - RUРУБ22.52M) = 5.07% CHGZ’s 5.07% ROCE means that for every RUB100 you invest, the company creates RUB5.1.

Simply Wall St -

What Are The Drivers Of Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) Risks?

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … View our latest analysis for RN-Western Siberia An interpretation of CHGZ's beta RN-Western Siberia's beta of 0.82 indicates that the stock value will be less variable compared to the whole stock market. … CHGZ's beta implies it may be a stock that investors with high-beta portfolios might find relevant if they wanted to reduce their exposure to market risk, especially during times of downturns.

Simply Wall St -

Who Are The Largest Shareholders In Public Joint Stock Company RN-Western Siberia (MCX:CHGZ)?

Today, I will be analyzing Public Joint Stock Company RN-Western Siberia’s (MISX:CHGZ) recent ownership structure, an important but not-so-popular subject among individual investors. … Private Company Ownership Potential investors in CHGZ should also look at another important group of investors: private companies, with a stake of 90.42%, who are primarily invested because of strategic and capital gain interests. … Thus, potential investors should look into these business relations and check how it can impact long-term shareholder returns.Next Steps: A large shareholding of CHGZ by the general public could mean higher market liquidity to buy and sell shares for retail investors, and also the potential to have more influence over company policies as a collective.

Simply Wall St -

Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) Earnings Dropped -42.85%, How Did It Fare Against The Industry?

Measuring Public Joint Stock Company RN-Western Siberia's (MISX:CHGZ) track record of past performance is an insightful exercise for investors. … View our latest analysis for RN-Western Siberia Commentary On CHGZ's Past Performance To account for any quarterly or half-yearly updates, I use data from the most recent 12 months, which annualizes the most recent half-year data, or in some cases, the latest annual report is already the most recent financial year data. … Given that these figures are fairly myopic, I have computed an annualized five-year value for CHGZ's net income, which stands at RUРУБ97.95M This means that despite the fact that earnings growth was negative from last year, over time, RN-Western Siberia's profits have been rising on average.

Simply Wall St -

With An ROE Of 4.05%, Has Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) Management Done Well?

Check out our latest analysis for RN-Western Siberia Breaking down Return on Equity Firstly, Return on Equity, or ROE, is simply the percentage of last years’ earning against the book value of shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is measured against cost of equity in order to determine the efficiency of RN-Western Siberia’s equity capital deployed. … Currently, RN-Western Siberia has no debt which means its returns are driven purely by equity capital.

Simply Wall St -

Does Public Joint Stock Company RN-Western Siberia's (MCX:CHGZ) PE Ratio Signal A Buying Opportunity?

Formula Price-Earnings Ratio = Price per share ÷ Earnings per share P/E Calculation for CHGZ Price per share = RUB25 Earnings per share = RUB4 ∴ Price-Earnings Ratio = RUB25 ÷ RUB4 = 6.3x On its own, the P/E ratio doesn’t tell you much; however, it becomes extremely useful when you compare it with other similar companies. … For example, if you accidentally compared higher growth firms with CHGZ, then CHGZ’s P/E would naturally be lower since investors would reward its peers’ higher growth with a higher price. … Alternatively, if you inadvertently compared less risky firms with CHGZ, CHGZ’s P/E would again be lower since investors would reward its peers’ lower risk with a higher price as well.

Simply Wall St -

Company Info

Description

Public Joint Stock Company RN-Western Siberia provides legal, administrative, and archiving services in Russia. The company offers collection, storage, and registration services. It also provides loans; and temporary property leasing services. The company was formerly known as Public Joint Stock Company Chernogorneft and changed its name to Public Joint Stock Company RN-Western Siberia in December 2016. The company was founded in 1992 and is headquartered in Nizhnevartovsk, Russia. Public Joint Stock Company RN-Western Siberia operates as a subsidiary of Open Joint Stock Company RN Holding

Details
Name: Public Joint Stock Company RN-Western Siberia
CHGZ
Exchange: MISX
Founded: 1992
RUB816,528,310
26,771,420
Website: http://www.chernogorneft.ru
Address: Public Joint Stock Company RN-Western Siberia
31 Aviatorov Street,
Western Industrial Hub,
Nizhnevartovsk,
628600,
Russia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
MISX CHGZ Common Shares Micex - Rts RU RUB 18. Apr 1995
Number of employees
Current staff
Staff numbers
0
RN-Western Siberia employees.
Industry
Research and Consulting Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 21:34
End of day share price update: 2019/04/18 00:00
Last earnings filing: 2019/02/05
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.